33 Medical, Inc.
Home
Our Team
Our Products
  • NuvoDisc Microgel™
  • Tekon TDR®
Clinical Trials
Contact Us
Patents
33 Medical, Inc.
Home
Our Team
Our Products
  • NuvoDisc Microgel™
  • Tekon TDR®
Clinical Trials
Contact Us
Patents
More
  • Home
  • Our Team
  • Our Products
    • NuvoDisc Microgel™
    • Tekon TDR®
  • Clinical Trials
  • Contact Us
  • Patents
  • Home
  • Our Team
  • Our Products
    • NuvoDisc Microgel™
    • Tekon TDR®
  • Clinical Trials
  • Contact Us
  • Patents

The Team

WESLEY SIERK Chief Executive Officer Services/Board Chairman

WESLEY SIERK Chief Executive Officer Services/Board Chairman

WESLEY SIERK Chief Executive Officer Services/Board Chairman

Successful entrepreneur and business leader with nearly 30 years of experience building and guiding companies in the

risk management, tax reduction and asset

protection sectors.

JEFF ZISSELMAN Chief Operating Officer

WESLEY SIERK Chief Executive Officer Services/Board Chairman

WESLEY SIERK Chief Executive Officer Services/Board Chairman

Spearheaded the development of an

international business and sales team in the health and wellness sector.

JOHN EDWARDS, M.D. Chief Medical Officer

WESLEY SIERK Chief Executive Officer Services/Board Chairman

SUSAN DRAPEAU, PhD Chief Regulator Advisor

 Graduate from the University of Iowa Medical School. Neurosurgery residency at Indiana University, Established well-respected neurosurgical practices.

SUSAN DRAPEAU, PhD Chief Regulator Advisor

WESLEY SIERK Chief Executive Officer Services/Board Chairman

SUSAN DRAPEAU, PhD Chief Regulator Advisor

  Brings 24+ years in cell therapy, biologics, and medical device development.

The Advisory Board

SCOTT BRUDER, M.D., PhD Chief Strategy Advisor

SCOTT BRUDER, M.D., PhD Chief Strategy Advisor

SCOTT BRUDER, M.D., PhD Chief Strategy Advisor

  Dr. Bruder brings 25+ years of healthcare industry experience, including roles as CSO & CMO at Stryker Corporation and CTO at Becton, Dickinson & Company, before founding BCVG in 2015.

THOMAS JG HUOT, M.D., PhD Industry Advisor

SCOTT BRUDER, M.D., PhD Chief Strategy Advisor

SCOTT BRUDER, M.D., PhD Chief Strategy Advisor

  Dr. Huot brings 20+ years in healthcare and biotech investments. He founded Novalis Advisors in 2022, providing strategic services across healthcare and bioscience sectors.

MARK LAWRENCE Financial Advisor

SCOTT BRUDER, M.D., PhD Chief Strategy Advisor

MARK LAWRENCE Financial Advisor

 CFO of Aptive Environmental, previously served as CFO of Nu Skin Enterprises and head of finance for Amazon's Lab126, where he led global finance operations .

Clinical Advisory Board

JON OBRAY, M.D.

MARK STOUFFER, M.D.

RICK OBRAY, M.D.

Spine and Musculoskeletal Fellowship – John Hopkins


Interventional Pain Fellowship – Mayo Clinic

RICK OBRAY, M.D.

MARK STOUFFER, M.D.

RICK OBRAY, M.D.

Spine and Musculoskeletal Fellowship – John Hopkins


Interventional Pain Fellowship – Mayo Clinic

JOHN EDWARDS, M.D.

MARK STOUFFER, M.D.

MARK STOUFFER, M.D.

University of Iowa Medical, Neurosurgery


Residency at Indiana University

MARK STOUFFER, M.D.

MARK STOUFFER, M.D.

MARK STOUFFER, M.D.

Medical College of Wisconsin, Doctor of Medicine


Texas Back Institute, Spine Surgery Fellow

33 Medical, Inc.

 NuvoDisc Microgel™ and Tekon TDR® are investigational devices that are not approved or cleared by the FDA in the United States. 


Copyright © 2024 33 Medical, Inc. - All Rights Reserved.

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept